Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant - 05/08/19
Doi : 10.1016/j.jaci.2019.04.006
Jeffery J. Auletta, MD a, b, c, j, n 
, Pablo J. Sánchez, MD b, d, j, Erin K. Meyer, DO, MPH a, e, Lynn C. O'Donnell, PhD k, l, Kevin A. Cassady, MD b, i, j, n, Christopher P. Ouellette, MD b, c, j, Shaina Hecht, MD b, j, Alejandro Diaz, MD b, j, Leeann R. Pavlek, MD d, j, Douglas P. Salamon, BS, MB(ASCP)SV f, Christina L. Gallagher, RN, BSN a, Hillary Bradbury, BS l, Sarah L. Welfley, RN, MSN, CPNP-AC a, Jacqueline Magers, PharmD, BCPS g, Debra L. Armbruster, NNP m, Margaret G. Lamb, MD a, i, j, Robin J. Nakkula, MD i, Kevin Bosse, PhD h, Dean A. Lee, MD, PhD a, i, j, n
, Pablo J. Sánchez, MD b, d, j, Erin K. Meyer, DO, MPH a, e, Lynn C. O'Donnell, PhD k, l, Kevin A. Cassady, MD b, i, j, n, Christopher P. Ouellette, MD b, c, j, Shaina Hecht, MD b, j, Alejandro Diaz, MD b, j, Leeann R. Pavlek, MD d, j, Douglas P. Salamon, BS, MB(ASCP)SV f, Christina L. Gallagher, RN, BSN a, Hillary Bradbury, BS l, Sarah L. Welfley, RN, MSN, CPNP-AC a, Jacqueline Magers, PharmD, BCPS g, Debra L. Armbruster, NNP m, Margaret G. Lamb, MD a, i, j, Robin J. Nakkula, MD i, Kevin Bosse, PhD h, Dean A. Lee, MD, PhD a, i, j, n a Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio
b Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio
c Host Defense Program, Nationwide Children's Hospital, Columbus, Ohio
d Center for Perinatal Research and Neonatology, Nationwide Children's Hospital, Columbus, Ohio
e Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio
f Laboratory of Microbiology/Immunoserology, Nationwide Children's Hospital, Columbus, Ohio
g Clinical Pharmacy, Nationwide Children's Hospital, Columbus, Ohio
h Drug and Device Development Services, Nationwide Children's Hospital, Columbus, Ohio
i Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Columbus, Ohio
j Department of Pediatrics, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio
k Division of Hematology, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio
l Cell Therapy Laboratory, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University, Columbus, Ohio
m Ohio State University Wexner Medical Center, Columbus, Ohio
n Ohio State University Comprehensive Cancer Center, Columbus, Ohio
| Research was supported by the Ohio State University Cancer Center Core Grant (National Institutes of Health/National Cancer Institute P30CA016058). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2019
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 144 - N° 2
P. 594 - août 2019 Retour au numéro
Article précédent
- Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies
- Cinzia Milito, Federica Pulvirenti, Francesco Cinetto, Vassilios Lougaris, Annarosa Soresina, Antonio Pecoraro, Alessandra Vultaggio, Maria Carrabba, Giuseppe Lassandro, Alessandro Plebani, Giuseppe Spadaro, Andrea Matucci, Giovanna Fabio, Rosa Maria Dellepiane, Baldassarre Martire, Carlo Agostini, Damiano Abeni, Stefano Tabolli, Isabella Quinti
- Tamoxifen restores extracellular trap formation in neutrophils from patients with chronic granulomatous disease in a reactive oxygen species–independent manner
- Atul Sharma, Katelyn McCann, Jitendra Kumar Tripathi, Pooja Chauhan, Christa Zerbe, Bibhuti B. Mishra, Steven M. Holland, Jyotika Sharma
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?